TrAMPoline Pharma
Manufacturing · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
12635 E Montview Blvd Ste 125, Aurora, C...Website
www.trampolinepharma.comRevenue
$7.2 MillionIndustry
About TrAMPoline Pharma
TrAMPoline Pharma is a cellular immunotherapy company focused on developing personalized therapies for solid tumor cancers, particularly through their lead candidate, MightyTIL. This gene-engineered tumor infiltrating lymphocyte therapy targets orphan cancer indications and has shown enhanced anti-tumor activity in preclinical models. The company aims to address the significant unmet needs in solid tumor treatment, where conventional immunotherapies often fail. Their patented coR8:Amp technology enhances T cell activation and targeting, offering a promising approach to combat cancer.Explore more
TrAMPoline Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to TrAMPoline Pharma
Compare insights from companies similar to TrAMPoline Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
TrAMPoline Pharma Tech Stack
A closer look at the technologies used by TrAMPoline Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TrAMPoline Pharma
Sign Up For FreeTo access detailed company insights
TrAMPoline Pharma is a cellular immunotherapy company focused on developing personalized therapies for solid tumor cancers, particularly through their lead candidate, MightyTIL. This gene-engineered tumor infiltrating lymphocyte therapy targets orphan cancer indications and has shown enhanced anti-tumor activity in preclinical models. The company a... Read More
